Loading clinical trials...
Loading clinical trials...
Spinal metastases account for 60% of all malignant bone metastases and represent a medically important treatment goal. For patients with malignant tumors diagnosed at this stage, performing En bloc sp...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
National Taiwan University Hospital
NCT07197645 · Bone Pain, Metastatic Bone Tumor, and more
NCT07471022 · Bone Metastases of a Malignant Tumor, Metastatic Bone Tumor
NCT05058014 · Metastatic Bone Tumor
NCT04660591 · Metastatic Bone Tumor, Pathological Fracture, and more
NCT03468075 · Sarcoma, Soft Tissue Sarcoma, and more
National Taiwan University Hospital
Taipei
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions